1,654 results on '"Bresolin, Nereo"'
Search Results
2. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
3. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
4. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
5. Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
6. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
7. Clinical, neuroradiological and genetic findings in a cohort of patients with multiple Cerebral Cavernous Malformations
8. Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy
9. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
10. Safety and efficacy of rt-PA treatment for acute stroke in pseudoxanthoma elasticum: the first report
11. Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
12. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
13. Animal Models of CMT2A: State-of-art and Therapeutic Implications
14. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives
15. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
16. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
17. Mental health and coping strategies in families of children and young adults with muscular dystrophies
18. Molecular Approaches for the Treatment of Pompe Disease
19. Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy
20. Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
21. Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice
22. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis
23. Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
24. Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy
25. R-Loops in Motor Neuron Diseases
26. Identification of a Putative Pathway for the Muscle Homing of Stem Cells in a Muscular Dystrophy Model
27. Cell Therapy of α-Sarcoglycan Null Dystrophic Mice through Intra-Arterial Delivery of Mesoangioblasts
28. A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation
29. Hereditary hemorrhagic telangiectasia associated with cortical development malformation due to a start loss mutation in ENG
30. Intraarterial Injection of Muscle-Derived CD34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
31. Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
32. Expanding the clinical spectrum of the mitochondrial mutation A13084T in the ND5 gene
33. Late-onset leukoencephalopathy in a patient with recessive EARS2 mutations
34. Aging-Dependent Large Accumulation of Point Mutations in the Human mtDNA Control Region for Replication
35. Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2A
36. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
37. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders
38. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
39. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
40. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents
41. Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
42. Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
43. Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss
44. Reply: DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions
45. Subclinical Leber’s hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye
46. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
47. New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients
48. Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene
49. MicroRNAs as serum biomarkers in Becker muscular dystrophy
50. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.